Article
Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin.
Oncogene - 8 Feb 2007
Bai Y, Liu Y-J, Wang H, Xu Y, Stamenkovic I, Yu Q
Abstract excerpt
Mutation or loss of expression of merlin is responsible for neurofibromatosis type 2 (NF2), which is characterized by the development of schwannomas and other tumors of the nervous system. Like the ERM (ezrin-radixin-moesin) proteins, merlin interacts with CD44, a cell-surface receptor for hyaluronan (HA) that promotes tumorigenesis. However, the relationship between merlin and CD44 and the mechanism by which...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
